Drug-making companies and researchers around the world are working day and night on the Covid-19 vaccine. They have conducted large numbers of trials on the vaccine. There are thousands of candidates involved in this work. As a result, many helpers are also working on this cause.
As we know many companies have disclosed their initial findings. Canadian and European regulatory authorities are already reviewing the results and data in the early stages. the following is the news that we know about the delivery of the Covid-19 Vaccine.
Table of Contents
Who is furthest along with Covid-19 Vaccine?
U.S drug-making company Pfizer Inc and its partner BioNTech SE, U.S biotech Moderna Inc and Britain based AstraZeneca Plc with the help of researchers from the University of Oxford will provide the final results of their early bases trails.
In these trails companies are giving dummy shots to the volunteers. Then researchers research on the basis of experiment that the chances of Covid-19 in the volunteers who get the vaccine and who didn’t get it.
The researchers don’t know till the end either the volunteer has received the vaccine or not. The study depends on the patients that are naturally infected with the virus. It also includes the community and areas that have a great impact on them with the pandemic.
How the Covid-19 Vaccine will Work
The United States, The United Kingdom, and the World Health Organization have set almost similar standards for the vaccine. The vaccine must have to demonstrate at least 50% effectiveness.
The independent panels supervise the whole trail to check the safety and effectiveness of the vaccine. The data remains confidential from the company and researchers. The data safety and monitoring companies keep an eye on the milestones that are defined.
If the vaccine is better than the placebo than it can be used for emergencies. The trail can also be stopped if the panel thinks it is unsafe.
Yes, these will be the first approved vaccine. Although China and Russia are also working hard on this aim.
China has recently launched a trial vaccine given to thousands of people at high risk. China is expecting an early trail data in November. While Russia is expected to have a trail result of 40,000 people at the end of October or start of November.
